The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, ...

Anthem Biosciences IPO: The Bengaluru-based company, Anthem Biosciences, has secured Rs 1,016 crore from anchor investors ...

According to InvestorGain, the grey market premium (GMP) for the Anthem Biosciences IPO stood at Rs 107 as of 9:31 a.m. on ...

Anthem Biosciences raises Rs 1,016 crore from anchor investors ahead of its IPO. The IPO opens July 14-16, with a price band ...

Anthem Biosciences Limited's initial public offering (IPO) subscription begins on July 14, with details including price band and allotment date now available.

As investors await the opening of Anthem Biosciences IPO, here are the key strengths and risks outlined in its Red Herring ...

Anthem Biosciences, a Bengaluru-based biopharma company, is set to open its Rs 3,395-crore IPO from July 14 to July 16.

Bengaluru-based Anthem Biosciences has raised ₹1,016.02 crore from 60 institutional investors through its anchor book on July ...

On the financial front, Anthem reported a net profit of ₹451.3 crore for the financial year ended March 2025, up 22.9% from ...

Anthem Biosciences Ltd, an IPO-bound CRDMO, plans expansion in Karnataka with increased custom synthesis and fermentation ...